| Amount | Holding |
|---|---|
| 2.62% | SPDR® S&P Biotech ETF |
| 2.24% | Mercury Systems Inc |
| 2.01% | Inphi Corp |
| 1.97% | Horizon Therapeutics PLC |
| 1.73% | Lattice Semiconductor Corp |
| 1.70% | Maximus Inc |
| 1.68% | Chegg Inc |
| 1.63% | J2 Global Inc |
| 1.62% | Trex Co Inc |
| 1.54% | Rapid7 Inc |
Expense Ratio Rating
5 /10
Expense Rating
0 /10
Market Score
3 /10
Category Score
5 /10
Market Size
3 /10
Nuveen Small Cap Growth Opportunities Fund Class A
Expenses: 1.23% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why »
| Amount | Holding |
|---|---|
| 2.62% | SPDR® S&P Biotech ETF |
| 2.24% | Mercury Systems Inc |
| 2.01% | Inphi Corp |
| 1.97% | Horizon Therapeutics PLC |
| 1.73% | Lattice Semiconductor Corp |
| 1.70% | Maximus Inc |
| 1.68% | Chegg Inc |
| 1.63% | J2 Global Inc |
| 1.62% | Trex Co Inc |
| 1.54% | Rapid7 Inc |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map